Clinical Trials Browser

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Diseases, Urinary Bladder Neoplasms, Neoplasms, Neoplasms by Site, Recurrence, Urogenital Neoplasms, Urologic Diseases

NCT06479954 2025-10-02

Non Interventional Study to Investigate the Safety and Effectiveness in Patients With Relapsed and Refractory Multiple Myeloma Treated With Elranatamab Under the Actual Use.

Active not recruiting

1 enrolled

Plasma cell

Multiple Myeloma, Recurrence

NCT05148572 2025-07-02

PROSECT

Active not recruiting

101 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Recurrence

NCT05334719 2025-06-27

G-KNIGHT

Active not recruiting

500 enrolled

Gastrointestinal

Recurrence, Stomach Neoplasms

NCT02562131 2025-06-06

PET-MR-PSA

Active not recruiting

80 enrolled

Recurrence

NCT02884102 2025-05-06

MMRF Molecular Profiling Protocol

Active not recruiting

1,000 enrolled

Plasma cell

Multiple Myeloma, Recurrence

NCT06014619 2025-04-04

Complications and Recurrences After Mohs Micrographic Surgery and Slow Mohs

Active not recruiting

500 enrolled

Dermatologic

Carcinoma, Basal Cell, Postoperative Complications, Recurrence, Skin Neoplasms, Hutchinson's Melanotic Freckle

NCT03191110 2025-04-01

COLON

Active not recruiting

2,000 enrolled

Gastrointestinal

Colonic Neoplasms, Recurrence, Colorectal Neoplasms

NCT03336931 2024-04-23

PRISM

Active not recruiting

550 enrolled

Neoplasms, Recurrence

NCT06246227 2024-03-12

ctDNA for Early Detection of Recurrence in Melanoma

Active not recruiting

467 enrolled

Dermatologic

Melanoma, Recurrence

NCT06143644 2023-12-04

Predictive Value of Postoperative Circulating Tumor DNA Monitoring for Colorectal Cancer Recurrence

Active not recruiting

220 enrolled

Gastrointestinal

Recurrence, Colorectal Neoplasms

Clinical Trials

Financial Distress in Advanced Cancer Patients

EPKEY_HSR

A Real-World Study of Trastuzumab Rezetecan in HER2+ Solid Tumors

Can Recurrence of Cancer in the Oropharynx be Detected by Blood Samples?

CISTO

Non Interventional Study to Investigate the Safety and Effectiveness in Patients With Relapsed and Refractory Multiple Myeloma Treated With Elranatamab Under the Actual Use.

PROSECT

G-KNIGHT

PET-MR-PSA

MMRF Molecular Profiling Protocol

Complications and Recurrences After Mohs Micrographic Surgery and Slow Mohs

COLON

PRISM

ctDNA for Early Detection of Recurrence in Melanoma

Predictive Value of Postoperative Circulating Tumor DNA Monitoring for Colorectal Cancer Recurrence